- Home
- DNUT vs TERN Comparison
DNUT vs TERN Comparison
Compare DNUT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- TERN
- Stock Information
- Founded
- DNUT 1937
- TERN 2017
- Country
- DNUT United States
- TERN United States
- Employees
- DNUT N/A
- TERN N/A
- Industry
- DNUT Food Chains
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DNUT Consumer Staples
- TERN Health Care
- Exchange
- DNUT Nasdaq
- TERN Nasdaq
- Market Cap
- DNUT 578.7M
- TERN 634.5M
- IPO Year
- DNUT 2021
- TERN 2021
- Fundamental
- Price
- DNUT $3.13
- TERN $7.13
- Analyst Decision
- DNUT Buy
- TERN Buy
- Analyst Count
- DNUT 6
- TERN 6
- Target Price
- DNUT $6.22
- TERN $13.99
- AVG Volume (30 Days)
- DNUT 3.6M
- TERN 1.1M
- Earning Date
- DNUT 11-06-2025
- TERN 11-11-2025
- Dividend Yield
- DNUT 3.37%
- TERN N/A
- EPS Growth
- DNUT N/A
- TERN N/A
- EPS
- DNUT N/A
- TERN N/A
- Revenue
- DNUT $1,538,841,000.00
- TERN N/A
- Revenue This Year
- DNUT N/A
- TERN N/A
- Revenue Next Year
- DNUT $2.93
- TERN N/A
- P/E Ratio
- DNUT N/A
- TERN N/A
- Revenue Growth
- DNUT N/A
- TERN N/A
- 52 Week Low
- DNUT $2.50
- TERN $1.87
- 52 Week High
- DNUT $12.68
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- DNUT 40.87
- TERN 54.96
- Support Level
- DNUT $2.95
- TERN $6.78
- Resistance Level
- DNUT $3.24
- TERN $7.67
- Average True Range (ATR)
- DNUT 0.18
- TERN 0.43
- MACD
- DNUT -0.04
- TERN -0.06
- Stochastic Oscillator
- DNUT 19.57
- TERN 39.81
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.